Ruth BIELSA GUIVERNAU,Roland CHERIF-CHEIKH,Julie FOURNES,Daniel MARTINEZ LORENTE,Anne PETIT,Joël RICHARD
申请号：
US14903010
公开号：
US20160151447A1
申请日:
2014.07.08
申请国别(地区):
US
年份:
2016
代理人:
摘要：
A pharmaceutical composition for a sustained release of peptide therapeutics, in particular for a sustained release compatible with therapeutic treatments of at least two months. In an embodiment, the composition comprises lanreotide as an active agent, a hydrosoluble co-solvent, and water with the pH of the composition being from 4.0 to 7.5.
